Α Multicenter Retrospective Study Evaluating Brivaracetam in the Treatment of Epilepsies in Clinical Practice

Brivaracetam (BRV) is the latest approved antiepileptic drug. The aim of the study was to evaluate the efficacy and tolerability of BRV in everyday clinical practice. In this retrospective, observational, multicenter study, data from epilepsy patients receiving BRV from January 2018 to July 2019 wer...

Descripción completa

Detalles Bibliográficos
Autores principales: Stefanatou, Maria, Vasileiadou Kapetanou, Eirini, Kimiskidis, Vasilios K., Papaliagkas, Vasileios, Polychronopoulos, Panagiotis, Markoula, Sofia, Charisiou, Kleoniki, Kazis, Dimitrios, Verentzioti, Anastasia, Patrikelis, Panayiotis, Alexoudi, Athanasia, Gatzonis, Stylianos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7923268/
https://www.ncbi.nlm.nih.gov/pubmed/33669900
http://dx.doi.org/10.3390/ph14020165

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7923268/
https://www.ncbi.nlm.nih.gov/pubmed/33669900
http://dx.doi.org/10.3390/ph14020165

Ejemplares similares